Keep your critical coding and billing tools with you no matter where you work.
Create your Find-A-Code account today!
tci Part B Insider - 2012 Issue 21
Reader Question: Don't Blithely Report Cancer Diagnoses
Question: My physician removed a patient's second lesion. The path reported severe dysplastic junctional melanocytic nevus exhibiting severe architectural disorder and melanocytic cytologic atypia with features of regression extending to the section edge. He noted that "Re-excision is required." Should I bill from the 11600-11646 series? The first lesion removal was billed as benign.Answer: This is still not cancer, but the doctor needed to remove this type of lesion because it puts the patient at risk for developing melanoma. Remember, you should always be cautious when applying a cancer diagnosis to a patient's claim, because this...
To read the full article, sign in and subscribe to tci Part B Insider.
Keep pace with evolving Medicare regulations with timely analysis of critical updates interpreted in an easy-to-follow, easy-to-apply format. Your subscription to TCI’s Part B Insider will equip you to navigate code and guideline changes, CCI edits, and revisions to modifiers, the fee schedule, OIG target areas, and more.
Current newsletters added each month
Fully searchable archives - over 4800 articles
ALL years/issues back to 2003 organized by year and issue
Codes mentioned in articles are linked to Code Information pages
Code Information pages link back to related articles
This feature is currently unavailable for online purchase. For more information, please call 801-770-4203 or Contact Us.